What does CUSIP 03152W109 represent in this 13F holders report?

CUSIP 03152W109 is the security identifier for FOLD - Amicus Therapeutics Inc - Common Stock used to aggregate holder disclosures.

How many institutions held FOLD - Amicus Therapeutics Inc - Common Stock in Q4 2018?

182 institutional investors reported FOLD - Amicus Therapeutics Inc - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

Amicus Therapeutics Inc - Common Stock (FOLD)

CUSIP: 03152W109

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 314,439,173
Total 13F shares: 231,135,366
Share change: +2,874,101
Total reported value: $2,206,742,744
Put/Call ratio: 25%
Price per share: $9.58
Number of holders: 182
Value change: +$14,137,230
Number of buys: 86
Number of sells: 91

Quarterly Holders Quick Answers

What is CUSIP 03152W109?
CUSIP 03152W109 identifies FOLD - Amicus Therapeutics Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 03152W109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of FOLD - Amicus Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PERCEPTIVE ADVISORS LLC	13F	Company	6.6%	20,694,424	$250,196,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	5.3%	16,807,772	$203,205,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	5.2%	16,374,336	$197,967,000	—	30 Sep 2018	13F
FMR LLC	13F	Company	4.3%	13,463,780	$162,777,000	—	30 Sep 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	3.2%	10,071,964	$121,770,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	3%	9,491,113	$114,750,000	—	30 Sep 2018	13F
Avoro Capital Advisors LLC	13F	Company	3%	9,333,132	$112,838,000	—	30 Sep 2018	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.8%	8,806,359	$106,469,000	—	30 Sep 2018	13F
Redmile Group, LLC	13F	Company	2.7%	8,402,617	$101,588,000	—	30 Sep 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.2%	7,001,370	$84,648,000	—	30 Sep 2018	13F
Palo Alto Investors LP	13F	Company	2%	6,366,147	$76,967,000	—	30 Sep 2018	13F
Invesco Ltd.	13F	Company	1.8%	5,618,022	$67,922,000	—	30 Sep 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.5%	4,867,290	$58,846,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	1.4%	4,515,225	$54,589,000	—	30 Sep 2018	13F
Artal Group S.A.	13F	Company	1.3%	4,000,000	$48,360,000	—	30 Sep 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	1.2%	3,741,654	$45,237,000	—	30 Sep 2018	13F
FRANKLIN RESOURCES INC	13F	Company	1.1%	3,498,881	$42,302,000	—	30 Sep 2018	13F
Marshall Wace North America L.P.	13F	Company	0.98%	3,068,679	$37,100,000	—	30 Sep 2018	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.84%	2,640,413	$31,923,000	—	30 Sep 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.83%	2,607,748	$31,527,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.82%	2,566,712	$31,031,000	—	30 Sep 2018	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.81%	2,541,095	$30,721,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.79%	2,488,634	$30,088,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.78%	2,445,877	$29,571,000	—	30 Sep 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.76%	2,400,674	$29,024,000	—	30 Sep 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.74%	2,329,200	$28,160,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.65%	2,047,159	$24,750,000	—	30 Sep 2018	13F
Bank of New York Mellon Corp	13F	Company	0.65%	2,040,353	$24,668,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.64%	2,002,741	$24,213,000	—	30 Sep 2018	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.59%	1,859,320	$22,478,000	—	30 Sep 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.57%	1,787,994	$21,617,000	—	30 Sep 2018	13F
ORBIMED ADVISORS LLC	13F	Company	0.56%	1,763,277	$21,318,000	—	30 Sep 2018	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.54%	1,696,320	$20,509,000	—	30 Sep 2018	13F
CITIGROUP INC	13F	Company	0.53%	1,682,103	$20,337,000	—	30 Sep 2018	13F
Novo Holdings A/S	13F	Company	0.52%	1,647,870	$19,923,000	—	30 Sep 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.51%	1,617,664	$19,558,000	—	30 Sep 2018	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.49%	1,547,481	$18,709,000	—	30 Sep 2018	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.48%	1,499,686	$18,131,000	—	30 Sep 2018	13F
NORGES BANK	13F	Company	0.47%	1,476,707	$17,854,000	—	30 Sep 2018	13F
LORD, ABBETT & CO. LLC	13F	Company	0.46%	1,440,999	$17,422,000	—	30 Sep 2018	13F
Tourbillon Capital Partners, L.P.	13F	Company	0.45%	1,414,130	$17,097,000	—	30 Sep 2018	13F
AXA S.A.	13F	Company	0.39%	1,218,691	$14,734,000	—	30 Sep 2018	13F
MARSHALL WACE, LLP	13F	Company	0.37%	1,165,941	$14,096,000	—	30 Sep 2018	13F
Grosvenor Holdings, L.L.C.	13F	Company	0.37%	1,160,022	$14,025,000	—	30 Sep 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	1,034,905	$12,513,000	—	30 Sep 2018	13F
Rock Springs Capital Management LP	13F	Company	0.32%	1,000,000	$12,090,000	—	30 Sep 2018	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.31%	976,570	$11,807,000	—	30 Sep 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.31%	976,456	$11,806,000	—	30 Sep 2018	13F
Tekla Capital Management LLC	13F	Company	0.28%	875,304	$10,582,000	—	30 Sep 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.24%	756,186	$9,142,000	—	30 Sep 2018	13F

Institutional Holders of Amicus Therapeutics Inc - Common Stock (FOLD) as of Q4 2018

As of 31 Dec 2018, Amicus Therapeutics Inc - Common Stock (FOLD) was held by 182 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 231,135,366 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, FMR LLC, Vanguard Group Inc, BlackRock Inc., JANUS HENDERSON GROUP PLC, venBio Select Advisor LLC, JENNISON ASSOCIATES LLC, STATE STREET CORP, Redmile Group, LLC, and WELLINGTON MANAGEMENT GROUP LLP. This page lists 182 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

198

Q4 2018 holders

182

Holder diff

-16

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.